Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice

European Journal of Immunology

Volumn 44, Issue 4, 2014, Pages 1170-1180

  Nikoopour, Enayat ^a   Cheung, Rebecca ^a   Bellemore, Stacey ^a   Krougly, Olga ^a   Lee Chan, Edwin ^a   Stridsberg, Mats ^b   Singh, Bhagirath ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

BDC2.5 T cells; Chromogranin A; Type 1 diabetes

Indexed keywords

ALANINE; AMINO ACID; AUTOANTIGEN; CHROMOGRANIN A; CHROMOGRANIN A 17-38 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A33 A35 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A33 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A34 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A35 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A36 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A37 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A38 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A39 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A40 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A41 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 A42 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 R34 PEPTIDE ANTIBODY; CHROMOGRANIN A 29-42 S35 PEPTIDE ANTIBODY; CHROMOGRANIN A 31-42 PEPTIDE ANTIBODY; CHROMOGRANIN A 33-42 PEPTIDE ANTIBODY; CHROMOGRANIN A 34-42 PEPTIDE ANTIBODY; CHROMOGRANIN A 34-44 PEPTIDE ANTIBODY; EPITOPE; FREUND ADJUVANT; PEPTIDE; PEPTIDE ANTIBODY; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG; VASOSTATIN 1 PEPTIDE; WE 14 PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOTINYLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMORAL IMMUNITY; IC 50; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TITRIMETRY;

BDC2.5 T CELLS; CHROMOGRANIN A; I-AG7 PEPTIDE BINDING MOTIF; TYPE 1 DIABETES;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CHROMOGRANIN A; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL;

EID: 84897996686     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343986     Document Type: Article

References (29)

1. Nikoopour, E., Sandrock, C., Huszarik, K., Krougly, O., Lee-Chan, E., Masteller, E. L., Bluestone, J. A. et al., Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice. J. Immunol. 2011. 186: 3831-3835.
2. Stadinski, B. D., Delong, T., Reisdorph, N., Reisdorph, R., Powell, R. L., Armstrong, M., Piganelli, J. D. et al., Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 2010. 11: 225-231.
3. Helle, K. B., Regulatory peptides from chromogranin A and secretogranin II. Cell. Mol. Neurobiol. 2010. 30: 1145-1146.
4. Arden, S. D., Rutherford, N. G., Guest, P. C., Curry, W. J., Bailyes, E. M., Johnston, C. F. and Hutton, J. C., The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem. J. 1994. 298 (Pt 3): 521-528.
5. Hutton, J. C., Hansen, F. and Peshavaria, M., Beta-granins: 21 kDa co-secreted peptides of the insulin granule closely related to adrenal medullary chromogranin A. FEBS Lett. 1985. 188: 336-340.
6. Hutton, J. C., Davidson, H. W. and Peshavaria, M., Proteolytic processing of chromogranin A in purified insulin granules. Formation of a 20 kDa N-terminal fragment (betagranin) by the concerted action of a Ca2+-dependent endopeptidase and carboxypeptidase H (EC 3.4.17.10). Biochem. J. 1987. 244: 457-464.
7. Hutton, J. C., Davidson, H. W., Grimaldi, K. A. and Peshavaria, M., Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin. Biochem. J. 1987. 244: 449-456.
8. Stettler, H., Beuret, N., Prescianotto-Baschong, C., Fayard, B., Taupenot, L. and Spiess, M., Determinants for chromogranin A sorting into the regulated secretory pathway are also sufficient to generate granule-like structures in non-endocrine cells. Biochem. J. 2009. 418: 81-91.
9. Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 1089-1100.
10. Chen, W., Yewdell, J. W., Levine, R. L. and Bennink, J. R., Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J. Exp. Med. 1999. 189: 1757-1764.
11. Weiskopf, D., Schwanninger, A., Weinberger, B., Almanzar, G., Parson, W., Buus, S., Lindner, H. et al., Oxidative stress can alter the antigenicity of immunodominant peptides. J. Leukoc. Biol. 2010. 87: 165-172.
12. Delong, T., Baker, R. L., He, J., Barbour, G., Bradley, B. and Haskins, K., Diabetogenic T-cell clones recognize an altered peptide of chromogranin a. Diabetes 2012. 61: 3239-3246.
13. Chang, K. Y., Suri, A. and Unanue, E. R., Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm. Proteomics 2007. 7: 367-377.
14. Suri, A., Levisetti, M. G. and Unanue, E. R., Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr. Opin. Immunol. 2008. 20: 105-110.
15. Portela-Gomes, G. M. and Stridsberg, M., Selective processing of chromogranin A in the different islet cells in human pancreas. J. Histochem. Cytochem. 2001. 49: 483-490.
16. Stridsberg, M., Eriksson, B., Oberg, K. and Janson, E. T., A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. Regul. Pept. 2004. 117: 219-227.
17. Curry, W. J., Shaw, C., Johnston, C. F., Thim, L. and Buchanan, K. D., Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett. 1992. 301: 319-321.
18. Mohan, J. F., Petzold, S. J. and Unanue, E. R., Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J. Exp. Med. 2011. 208: 2375-2383.
19. Crawford, F., Stadinski, B., Jin, N., Michels, A., Nakayama, M., Pratt, P., Marrack, P. et al., Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc. Natl. Acad. Sci. USA 2011. 108: 16729-16734.
20. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., Rothbard, J. B. and Allen, P. M., Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995. 2: 655-663.
21. Felix, N. J. and Allen, P. M., Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 2007. 7: 942-953.
22. Wucherpfennig, K. W., Allen, P. M., Celada, F., Cohen, I. R., De, B. R., Garcia, K. C., Goldstein, B. et al., Polyspecificity of T cell and B cell receptor recognition. Semin. Immunol. 2007. 19: 216-224.
23. Mohan, J. F., Levisetti, M. G., Calderon, B., Herzog, J. W., Petzold, S. J. and Unanue, E. R., Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat. Immunol. 2010. 11: 350-354.
24. Parmer, R. J., Mahata, M., Mahata, S., Sebald, M. T., O'Connor, D. T. and Miles, L. A., Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J. Biol. Chem. 1997. 272: 1976-1982.
25. Colombo, B., Longhi, R., Marinzi, C., Magni, F., Cattaneo, A., Yoo, S. H., Curnis, F. et al., Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion. J. Biol. Chem. 2002. 277: 45911-45919.
26. Byersdorfer, C. A., Schweitzer, G. G. and Unanue, E. R., Diabetes is predicted by the beta cell level of autoantigen. J. Immunol. 2005. 175: 4347-4354.
27. Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L. et al., Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005. 435: 220-223.
28. Portela-Gomes, G. M., Gayen, J. R., Grimelius, L., Stridsberg, M. and Mahata, S. K., The importance of chromogranin A in the development and function of endocrine pancreas. Regul. Pept. 2008. 151: 19-25.
29. Tota, B., Quintieri, A. M., Di, F. V. and Cerra, M. C., New biological aspects of chromogranin A-derived peptides: focus on vasostatins. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2007. 147: 11-18.